VCM
RGNX icon

Versant Capital Management’s Regenxbio RGNX Stock Holding History

Versant Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.8K Buy
2,741
+1,032
+60% +$8.56K ﹤0.01% 1655
2026
Q1 		$14.3K Hold
1,709
– – ﹤0.01% 1974
2025
Q4 		$24.6K Hold
1,709
– – ﹤0.01% 1509
2025
Q3 		$16.5K Buy
1,709
+1,485
+663% +$13.1K ﹤0.01% 1695
2025
Q2 		$1.84K Sell
224
-1,812
-89% -$15.2K ﹤0.01% 2401
2025
Q1 		$14.6K Buy
2,036
+635
+45% +$4.72K ﹤0.01% 1516
2024
Q4 		$10.8K Buy
1,401
+291
+26% +$2.73K ﹤0.01% 1353
2024
Q3 		$11.6K Buy
1,110
+1,081
+3,728% +$13.2K ﹤0.01% 1006
2024
Q2 		$339 Hold
29
– – ﹤0.01% 1842
2024
Q1 		$611 Hold
29
– – ﹤0.01% 1650
2023
Q4 		$521 Hold
29
– – ﹤0.01% 1666
2023
Q3 		$477 Sell
29
-26
-47% -$471 ﹤0.01% 1702
2023
Q2 		$1.1K Buy
55
+26
+90% +$501 ﹤0.01% 1569
2023
Q1 		$524 Hold
29
– – ﹤0.01% 1578
2022
Q4 		$658 Sell
29
-213
-88% -$4.82K ﹤0.01% 1394
2022
Q3 		$6K Buy
+242
New +$7.18K ﹤0.01% 798
2022
Q2 		– Sell
-65
Closed -$2K – 1615
2022
Q1 		$2K Buy
+65
New +$1.81K ﹤0.01% 1175
2019
Q2 		– Sell
-27
Closed -$1K – 1640
2019
Q1 		$1K Sell
27
-10
-27% -$495 ﹤0.01% 1480
2018
Q4 		$1K Buy
37
+6
+19% +$352 ﹤0.01% 1391
2018
Q3 		$2K Buy
31
+22
+244% +$1.58K ﹤0.01% 1319
2018
Q2 		$0 Buy
+9
New +$430 ﹤0.01% 1613

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Versant Capital Management's RGNX Position: Q2 2026 in Review

Versant Capital Management increased its Regenxbio (RGNX) stake by 60% in Q2 2026, buying an estimated $8.56K and bringing the position to 2,741 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

Versant Capital Management first reported a position in RGNX in Q2 2018 and has held it in 21 quarters since. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Versant Capital Management held 2,741 shares of Regenxbio worth $32.8K as of Q2 2026.
  • Versant Capital Management bought 1,032 Regenxbio shares in Q2 2026, an estimated $8.56K.
  • Regenxbio made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1655 holding.
  • Versant Capital Management first reported a position in Regenxbio in Q2 2018 and has held it in 21 quarters since.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.